Ann Pediatr Res | Volume 2, Issue 1 | Case Report | Open Access

Delayed Treatment Response in Pediatric Malaria with Atovaquone-Proguanil

Walter Dehority^1*, Andrew Renuart² and Rolando M Viani^3,4

¹Department of Pediatrics, The University of New Mexico, USA
²Department of Pediatric Anesthesiolgy, University of Pennsylvania Health System, USA
³Department of Pediatrics, University of California San Diego, USA
⁴Department of Pediatrics, Rady Children’s Hospital San Diego and AbbVie, USA

^*Correspondance to: Walter Dehority 

Fulltext PDF

Abstract

Atovaquone-Proguanil (AP) is frequently utilized for treatment of P. falciparum malaria. Independent of resistance, however delayed treatment responses and treatment failures may occur. We describe a case of delayed treatment response with AP in a 4-year-old child with P. falciparum infection, highlighting the limitations of this drug for the treatment of malaria.

Keywords:

Plasmodium falciparum; Atovaquone-proguanil; Pediatric; Treatment; Malaria

Citation:

Dehority W, Renuart A, Viani RM. Delayed Treatment Response in Pediatric Malaria with AtovaquoneProguanil. Ann Pediatr Res. 2018; 2(1): 1009.